标题
Current use of bone turnover markers in the management of osteoporosis
作者
关键词
-
出版物
CLINICAL BIOCHEMISTRY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-09-10
DOI
10.1016/j.clinbiochem.2022.09.002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The predictive value of bone turnover markers during discontinuation of alendronate: the PROSA study
- (2021) A.S. Sølling et al. OSTEOPOROSIS INTERNATIONAL
- Assessing bone formation in patients with chronic kidney disease using procollagen type I N-terminal propeptide (PINP): The choice of assay makes a difference
- (2021) Andreas Tridimas et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis
- (2021) Samuel D. Vasikaran et al. CALCIFIED TISSUE INTERNATIONAL
- Analytical evaluation of the Nittobo Medical tartrate resistant acid phosphatase isoform 5b (TRACP-5b) EIA and comparison with IDS iSYS in different clinically defined populations
- (2021) Etienne Cavalier et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Modeling‐Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial
- (2021) Erik F Eriksen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonates and the risk of atypical femur fractures
- (2021) Dennis M. Black et al. BONE
- Combination and sequential treatment in women with postmenopausal osteoporosis
- (2020) Athanasios D. Anastasilakis et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
- (2020) Dolores Shoback et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The challenge of long-term adherence: The role of bone turnover markers in monitoring bisphosphonate treatment of osteoporosis
- (2020) Andreas Fontalis et al. BONE
- Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS
- (2020) Elena Tsourdi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood
- (2020) Harjit P. Bhattoa et al. CLINICA CHIMICA ACTA
- Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis
- (2019) K.E. Naylor et al. OSTEOPOROSIS INTERNATIONAL
- Clinical Use of Bone Turnover Markers
- (2019) Douglas C. Bauer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
- (2019) Mattias Lorentzon et al. ADVANCES IN THERAPY
- Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2‐year Clinical Trial
- (2019) Athanasios D. Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone alkaline phosphatase: An important biomarker in chronic kidney disease – mineral and bone disorder
- (2019) Adrien Nizet et al. CLINICA CHIMICA ACTA
- Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
- (2019) P.D. Miller et al. OSTEOPOROSIS INTERNATIONAL
- Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti-Resorptive Drugs: A Meta-Regression
- (2018) Douglas C Bauer et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative
- (2018) Carolyn J Crandall et al. JOURNAL OF BONE AND MINERAL RESEARCH
- DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?
- (2017) Richard Eastell et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates
- (2017) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability
- (2017) P. Szulc et al. OSTEOPOROSIS INTERNATIONAL
- Antiresorptives: Safety Concerns—Clinical Perspective
- (2017) Jacques P. Brown TOXICOLOGIC PATHOLOGY
- KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
- (2017) Kidney International Supplements
- Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis
- (2016) Stuart M. Sprague et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Evaluation of serum bone alkaline phosphatase activity in patients with liver disease: Comparison between electrophoresis and chemiluminescent enzyme immunoassay
- (2016) Fangjie Zhan et al. CLINICA CHIMICA ACTA
- Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases
- (2016) Paolo Magni et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS — 2016
- (2016) Pauline M. Camacho et al. Endocrine Practice
- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- (2016) Robert A Adler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancel the denosumab holiday
- (2016) M. R. McClung OSTEOPOROSIS INTERNATIONAL
- Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?
- (2015) Pascale Chavassieux et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics
- (2015) A. W. Popp et al. OSTEOPOROSIS INTERNATIONAL
- Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
- (2015) K. E. Naylor et al. OSTEOPOROSIS INTERNATIONAL
- An overview of the metabolic functions of osteocalcin
- (2015) Jianwen Wei et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture
- (2014) Helena Johansson et al. CALCIFIED TISSUE INTERNATIONAL
- Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups
- (2014) Jane Burch et al. HEALTH TECHNOLOGY ASSESSMENT
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
- (2014) Aliya A Khan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- New bone-forming treatments for osteoporosis
- (2014) Socrates E. Papapoulos Nature Reviews Endocrinology
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- PINP as a biological response marker during teriparatide treatment for osteoporosis
- (2014) J. H. Krege et al. OSTEOPOROSIS INTERNATIONAL
- Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy
- (2014) Douglas C. Bauer et al. JAMA Internal Medicine
- Variability of New Bone Mineral Metabolism Markers in Patients Treated with Maintenance Hemodialysis: Implications for Clinical Decision Making
- (2013) Etienne Cavalier et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Bone Alkaline Phosphatase in CKD–Mineral Bone Disorder
- (2013) Sunita Sardiwal et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Genetic influence on bone phenotypes and body composition: a Swedish twin study
- (2013) Helene Wagner et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum
- (2012) Marja-Kaisa Koivula et al. CLINICAL BIOCHEMISTRY
- Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)
- (2012) Yoshiki Nishizawa et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspective
- (2012) Steven Boonen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone turnover markers: use in osteoporosis
- (2012) Kim Naylor et al. Nature Reviews Rheumatology
- International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis
- (2011) Samuel Vasikaran et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- ASBMR 30th Annual Meeting 1001-1300
- (2011) JOURNAL OF BONE AND MINERAL RESEARCH
- Official Positions for FRAX® Clinical Regarding Biochemical Markers
- (2011) Eugene V. McCloskey et al. JOURNAL OF CLINICAL DENSITOMETRY
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases
- (2011) L. Marin et al. ANNALS OF CLINICAL BIOCHEMISTRY
- 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
- (2010) A. Papaioannou et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase
- (2010) A.M. Parfitt et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
- (2010) Patrick Garnero et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry
- (2010) Erik F. Eriksen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The diagnosis of osteoporosis
- (2010) John A. Kanis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine
- (2010) Dennis A. Hanson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide
- (2010) R. Eastell et al. OSTEOPOROSIS INTERNATIONAL
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- Biology and Clinical Significance of Tartrate-Resistant Acid Phosphatases: New Perspectives on an Old Enzyme
- (2009) Anthony J. Janckila et al. CALCIFIED TISSUE INTERNATIONAL
- Bone turnover markers in the management of postmenopausal osteoporosis
- (2009) Jacques P. Brown et al. CLINICAL BIOCHEMISTRY
- Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis
- (2009) Pierre D Delmas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Assessing the Clinical Utility of Serum CTX in Postmenopausal Osteoporosis and Its Use in Predicting Risk of Osteonecrosis of the Jaw
- (2009) Sanford Baim et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide
- (2009) M.-K. Koivula et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Bone remodelling: its local regulation and the emergence of bone fragility
- (2008) T. John Martin et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy
- (2008) Jean-Yves Reginster et al. BONE
- Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women
- (2008) Julie Blouin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: A comparative review
- (2008) Markus Herrmann et al. CLINICA CHIMICA ACTA
- Utility of Biochemical Markers of Bone Turnover and Bone Mineral Density in Management of Osteoporosis
- (2008) Samuel D. Vasikaran CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*
- (2008) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started